Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention of cisplatin-induced acute nephrotoxicity
IRCT20180722040556N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in nephrotoxicity, sponsored by Isfahan University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
curcumin
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT20180722040556N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180722040556N8.